Table 1. Demographic data, ASA physical status, tumor location, surgical approach and pre-anesthetic therapy in dogs that underwent elective rostrotentorial or transfrontal craniectomy.
| Information recorded | Sevo-Op | Sevo-Dex | P value |
|---|---|---|---|
| No. of animals | 8 | 13 | - |
| Age (yr) | 9.64 (± 2.56) | 10.22 (± 1.85) | 0.59 |
| Sex (No.) | 5F, 3M | 6F, 7M | 0.66 |
| Breed (No.) | 1 Crossbreed; 1 French Bulldog; 1 German Shepherd; 1 Golden Retriever; 2 Labrador Retriever; 1 Springer Spaniel; 1 Staffordshire Bull Terrier | 2 Crossbreed; 1 Dobermann; 1 German Shepherd; 1 Labrador Retriever; 1 Newfoundland; 1 Poodle; 1 Springer Spaniel; 1 Stabyhoun; 1 Staffordshire Bull Terrier; 1 Weimaraner; 2 West Highland White Terrier | N/A |
| ASA status (No.) | 2 ASA-2, 6 ASA-3 | 3 ASA-2, 10 ASA-3 | 0.99 |
| Tumor location (No.) | 5 Frontal | 5 Frontal | 0.38 |
| 3 Olfactory | 6 Olfactory | ||
| 2 Olfactory + Frontal | |||
| Intra vs. extra-axial (No.) | 1 Intra-axial | 2 Intra-axial | 0.99 |
| 7 Extra-axial | 11 Extra-axial | ||
| Surgical approach (No.) | 2 Rostrotentorial | 2 Rostrotentorial | 0.62 |
| 6 Transfrontal | 11 Transfrontal | ||
| Pre-anesthetic therapy (No. [dose in mg/kg]) | 7 Mannitol (0.5) | 9 Mannitol (0.5) | 0.61 |
| 7 Phenobarbital (2.5 [1.6–2.9]) | 12 Phenobarbital (2.5 [1.5–3]) | 0.99 | |
| 8 Dexamethasone (0.2 [0.05–0.2]) | 11 Dexamethasone (0.2 [0.2–0.4]) | 0.50 |
Drug doses are expressed as [median (range)].
ASA, American Society of Anesthesiologists; Group Sevo-Op, sevoflurane and short acting opioid infusion; Group Sevo-Dex, sevoflurane and dexmedetomidine infusion; NA, not available.